Meridian Health Plan of Illinois Launches Telehealth for YouthCare Members via Blueberry Pediatrics

Meridian Health Plan of Illinois, a provider of managed care services for children, families, and individuals with complex medical needs, has expanded its telehealth program with Blueberry Pediatrics. Initially launched as a pilot in March 2024, the program will now…

Read MoreMeridian Health Plan of Illinois Launches Telehealth for YouthCare Members via Blueberry Pediatrics

Elation Health Survey: 66% of Primary Care Docs Say AI Reduces Administrative Burden

Elation Health, a clinical-first technology company driving innovation in primary care, today shared the results of its latest survey of 100 primary care physicians (PCPs). The survey provides valuable insights into the adoption and impact of artificial intelligence (AI) in…

Read MoreElation Health Survey: 66% of Primary Care Docs Say AI Reduces Administrative Burden

Bristol Myers Squibb Gets CHMP Nod for Opdivo + Yervoy in MSI-High Colorectal Cancer

Bristol Myers Squibb (NYSE: BMY) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of Opdivo® (nivolumab) in combination with Yervoy® (ipilimumab) for the first-line…

Read MoreBristol Myers Squibb Gets CHMP Nod for Opdivo + Yervoy in MSI-High Colorectal Cancer

Vektor Medical’s AI-Powered vMap Achieves 91% Accuracy in Distinguishing Ventricular Tachycardia Types

Vektor Medical, a leader in non-invasive arrhythmia analysis and localization, today announced new data demonstrating the enhanced capabilities of its AI-powered solution, vMap, for improving cardiac arrhythmia treatment. The data, to be presented at the American Heart Association (AHA) Scientific…

Read MoreVektor Medical’s AI-Powered vMap Achieves 91% Accuracy in Distinguishing Ventricular Tachycardia Types

Cofactor Genomics Expands OncoPrism Use After National Validation for Lung Cancer Immunotherapy

Cofactor Genomics, Inc., a clinical-stage company focused on bridging the precision medicine gap through RNA decoding, today announced the validation and launch of OncoPrism®-NSCLC, an RNA-based diagnostic test designed to predict response to immune checkpoint inhibitors (ICI) in patients with…

Read MoreCofactor Genomics Expands OncoPrism Use After National Validation for Lung Cancer Immunotherapy